However, a recent study showed that ASMTL-AS1 is highly expressed in HCC and favors malignant tumor phenotypes through miR-342-3p/YAP (Yes1-associated transcriptional regulator) signaling [12]. The gene discussed is ASMTL; the disease is hepatocellular carcinoma.